Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Looking for value? Find out what credit card has the best rewards and no annual fee to maximize your financial benefits without added costs.
28,655 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Solana posted the largest ETF inflow in months on February 25, signaling renewed institutional interest. Yet on-chain...
Oppenheimer boosts its Palo Alto Networks price target to $275 citing strong demand for the Idira identity security p...
A new AI-based forecast linked to Elon Musk’s Grok model signals a 15-25% Netflix jump within 30 days, centering on a...
Bitcoin moved sharply amid Middle East tensions and a U.S. strike on Iran, slipping before a quick rebound. Analysts ...
KeyBanc raises NVIDIA's price target to $300 ahead of May earnings, pointing to Blackwell and Rubin as near-term cata...
Investors face a 28% price return gap between XYLD and SPY as income-focused strategy meets growth potential. This re...
Vitalik Buterin unveils Sanctuary Tech, hinting at a new endgame for Ethereum. The idea arrives as macro volatility w...
Geopolitical tensions flare as Iran hints at escalation. The crypto suffers iran threatens mood weighs on Bitcoin and...
Netflix is set to release its Q2 earnings after the bell tonight, with investors watching ad revenue growth, content ...
A little-known rival to SCHD has delivered competitive long-run gains and steady monthly income, thanks to a mid-cap ...
Vanguard’s 8-for-1 split lowered VGT’s price, letting smaller investors pursue income strategies through covered call...